Indication
Transthyretin Amyloidosis with Polyneuropathy
The Transthyretin Amyloidosis with Polyneuropathy pipeline: 5 tracked drugs, 4 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Transthyretin Amyloidosis with Polyneuropathy, so this list is not complete.
4 approved / phase 41 Phase 3
Compare the share prices of listed companies in Transthyretin Amyloidosis with Polyneuropathy →
Market size not yet sourced. How markets are sized ↗